Aclaris Investigational Site

Nashville, Tennessee 37215

0 studies enrolling now · 5 studies all time

What they study most

Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Common Wart, Hidradenitis Suppurativa

Studies at this site

• ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• Safety Study of A-101 Topical Solution for the Treatment of Common Warts — Completed
• A Study of A-101 Topical Solution for the Treatment of Common Warts — Completed
• ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) — Stopped early
• A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts — Completed